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Abstract
Introduction Trauma scoring systems are important tools for outcome prediction and severity adjustment that informs 
trauma quality assessment and research. Discrimination and precision of such systems is tested in validation studies. The 
German TraumaRegister  DGU® (TR-DGU) and the Trauma Audit and Research Network (TARN) from the UK agreed on 
a cross-validation study to validate their prediction scores (RISC II and PS14, respectively).
Methods Severe trauma patients with an Injury Severity Score (ISS) ≥ 9 documented in 2015 and 2016 were selected in 
both registries (primary admissions only). The predictive scores from each registry were applied to the selected data sets. 
Observed and predicted mortality were compared to assess precision; area under the receiver operating characteristic curve 
was used for discrimination. Hosmer–Lemeshow statistic was calculated for calibration. A subgroup analysis including 
patients treated in intensive care unit (ICU) was also carried out.
Results From TR-DGU, 40,638 patients were included (mortality 11.7%). The RISC II predicted mortality was 11.2%, 
while PS14 predicted 16.9% mortality. From TARN, 64,622 patients were included (mortality 9.7%). PS14 predicted 10.6% 
mortality, while RISC II predicted 17.7%. Despite the identical cutof of ISS ≥ 9, patient groups from both registries showed 
considerable diference in need for intensive care (88% versus 18%). Subgroup analysis of patients treated on ICU showed 
nearly identical values for observed and predicted mortality using RISC II.
Discussion Each score performed well within its respective registry, but when applied to the other registry a decrease in 
performance was observed. Part of this loss of performance could be explained by diferent development data sets: the RISC 
II is mainly based on patients treated in an ICU, while the PS14 includes cases mainly cared for outside ICU with more 
moderate injury severity. This is according to the respective inclusion criteria of the two registries.
Conclusion External validations of prediction models between registries are needed, but may show that prediction models 
are not fully transferable to other health-care settings.
Keywords Severe injuries · Trauma registry · Survival · Prognosis · Score · Outcome
Introduction
Severe trauma is a major health problem where a lot of 
younger people are afected, as many would die or suf-
fer from long-term disability. Therefore, improvement of 
treatment and outcome is an important objective. Trauma 
registries are established in hospitals, regions or countries. 
They document patient’s demographics, circumstances of 
the accident, injuries, physiological reactions, pre-hospital 
and in-hospital care and outcome. This allows quantiica-
tion of the burden of injuries, and to compare it with the 
observed outcome. Based on these comparisons, treatment 
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options or diagnostic modalities may be evaluated. The per-
formance of hospitals can also be evaluated when observed 
mortality is compared to the expected outcome.
The TraumaRegister  DGU® (TR-DGU) of the German 
Trauma Society (DGU, Deutsche Gesellschaft für Unfallchi-
rurgie) and the Trauma Audit and Research Network 
(TARN) in the UK are trauma registries that have existed 
for more than 25 years. They provide regular quality audits 
and benchmarking data for their participating hospitals.
The main outcome measure for severely injured patients 
is still mortality. Mortality rates, however, depend on multi-
ple factors, including the patient’s condition (age, sex, exist-
ing diseases), the type of trauma (blunt or penetrating), the 
injuries (severity, number, and pattern), and the patients’ 
physiological reactions to these injuries (shock, uncon-
sciousness, coagulopathy, etc.). Case-mix adjustment ena-
bles comparison of hospital’s performance on a ‘like with 
like’ basis. Unadjusted mortality rates, for example, would 
penalize the work of large trauma centers where the most 
severe cases are treated. Susan Baker, who irst developed 
the Injury Severity Score (ISS), once quoted: ‘If you have 
never felt the need for any type of severity scoring system, 
then you probably have never had to explain how it is that 
the survival rate of 85% in your trauma center is actually 
better than the survival rate of 97% in some other hospital 
where the patients are much less seriously injured” [1]
Prognostic scoring systems using case-mix adjustment 
provide an estimate of the risk of death for each individual 
patient. Patient groups could then be evaluated by comparing 
their observed mortality rate with their average prognosis.
Both large trauma registries described above use such tools 
for outcome adjustment. The TR-DGU initially used the TRISS 
score for outcome adjustment [2]. In 2003, it changed to the 
Revised Injury Severity Classiication (RISC) score which has 
been developed and validated with data from the TR-DGU 
[3]. In 2013, an update of this score has been developed based 
on data from 2010–11, with validation on 2012 data [4]. The 
revised RISC II score has been used in the annual reports of 
the registry since 2013. TARN has also developed a prognostic 
score, which has evolved from the TRISS and has been used 
for quality assurance trauma care in the UK since 2004. The 
coeicients of this score are routinely updated to increase the 
precision of the prediction. The most recent version of this 
score is from 2017, but this paper uses the PS14 coeicients 
from the original publication [5]. The risk prediction models are 
described in the appendices. Table 1 highlights the fact that the 
inclusion criteria for both registries difer somewhat as do the 
variables utilized in risk adjustment. The TARN model has been 
validated in the National Trauma Databank [6], and the RISC 
II score has been validated repeatedly in TR-DGU data [3] and 
in Spanish [7] and Finish [8] data. However neither model has 
been previously tested in an external large European Trauma 
Registry, but this is valuable to understand their external validity.
The aim of this paper is to perform a cross-validation 
of both prognostic scoring systems using data from both 
Table 1  Patient inclusion criteria of both registries, and list of variables needed for score calculation (for details of score calculation, see 
“Appendix 1” and “Appendix 2”)
TraumaRegister DGU (TR-DGU) Trauma Audit and Research Network (TARN)
Founded 1993 1989
Inclusion criteria Alive on admission
 Trauma team activation
Admission via shock room
Need for intensive care (or death before ICU admission)
At least one of the following
 Hospital admission ≥ 3 days
 Intensive care admission
  Transfer to a tertiary/specialist center
 In-hospital death within 30 days
Exclusions Pre-hospital deaths
Severe burns
Drowning, poisoning, hanging
Isolated femur fractures
Pre-hospital deaths
Isolated femoral neck or single pubic ramus frac-
ture in patients > 65 years
Simple isolated injuries
Outcome prediction model Revised Injury Severity Classiication, version II (RISC II) Probability of Survival model, version 2014 (PS14)
Predictors Injury severity (worst AIS; second worst AIS; head AIS)
Age
Gender
Pupil size and reactivity [11]
Penetrating mechanism
Pre-injury ASA
GCS motor function
Cardio-pulmonary resuscitation
Blood pressure
Base deicit
Hemoglobin
Int. Normalized Ratio (INR)
Injury severity (ISS)
Age
Gender
Glasgow Coma Scale (GCS)
Charlson Comorbidity Index (CCI)
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registries, where score-based prognoses will be compared 
with the observed outcome.
Methods
Registries
The TraumaRegister  DGU® of the German Trauma Soci-
ety (Deutsche Gesellschaft für Unfallchirurgie, DGU) was 
founded in 1993. The aim of this multi-center database is a 
pseudonymized and standardized documentation of severely 
injured patients. Data are collected prospectively in four 
consecutive time phases from the site of the accident until 
discharge from hospital: (A) pre-hospital phase, (B) emer-
gency room and initial surgery, (C) intensive care unit (ICU) 
and (D) discharge. The documentation includes detailed 
information on demographics, injury pattern, comorbidities, 
pre- and in-hospital management, course on intensive care 
unit, relevant laboratory indings including data on transfu-
sion and outcome of each individual. The inclusion criterion 
is admission to hospital via the emergency room with subse-
quent admission to intensive care. Patients who reached the 
hospital alive but died before ICU admission are included 
as well (Table 1). Injuries are coded according to a reduced 
version of the Abbreviated Injury Scale (AIS) version 2005/
update 2008, where injuries of the same severity level were 
merged. The infrastructure for documentation, data man-
agement, and data analysis is provided by AUC—Academy 
for Trauma Surgery (AUC—Akademie der Unfallchirurgie 
GmbH), a company ailiated to the German Trauma Society. 
The scientiic leadership is provided by the Committee on 
Emergency Medicine, Intensive Care and Trauma Manage-
ment (Sektion NIS) of the German Trauma Society. The 
participating hospitals submit pseudonymized data into 
a central database via a web-based application. Scientiic 
data analysis is approved according to a peer review process 
established by Sektion NIS. The participating hospitals are 
primarily located in Germany (90%), but a rising number 
of hospitals of other countries contribute data as well (at 
the moment from Austria, Belgium, China, Finland, Lux-
embourg, Slovenia, Switzerland, The Netherlands, and the 
United Arab Emirates). Currently, approximately 35,000 
cases from more than 600 hospitals are entered into the 
database per year. Participation in TraumaRegister  DGU® 
is voluntary. For hospitals associated with TraumaNetzwerk 
 DGU® however, the entry of at least a basic data set is oblig-
atory for reasons of quality assurance.
TARN is an independent trauma audit which was founded 
in 1989. TARN is part of the University of Manchester. TARN 
is funded by its member National Health Service (NHS) and 
European hospitals by annual subscriptions, where the fees are 
based on their annual accident and emergency (A&E) attendance. 
TARN is overseen by a board consisting of health professionals 
from diferent backgrounds, specialties, skills and geography. 
The TARN Board meets twice a year to approves the 5-year 
strategic plan for TARN, agrees annual budget and fee structure 
and evaluates the performance of the research group and the per-
formance of the Clinical Audit Group. Data are recorded online 
through the bespoke TARN website. Every injury is recorded and 
deined according to the Abbreviated Injury Scale (AIS) diction-
ary version 2005/update 2008. This is used by trained coders to 
enable calculation of the Injury Severity Score (ISS). All trauma 
receiving hospitals in England, Wales and Northern Ireland are 
members, and also foreign hospitals from the Republic of Ireland, 
Copenhagen and Bern. There are approximately 230 hospitals 
contributing with 85,000 submissions annually. The inclusion 
criteria of TARN database are listed in Table 1.
Patients
Patients from both registries with an Injury Severity Score 
(ISS) ≥ 9 points were included and restricted to patients treated 
in German or English hospitals, respectively. Patients trans-
ferred in from other hospitals were excluded, since the initial 
treatment may have altered their physiology. Patients who were 
transferred out within 48 h were also excluded, since outcome 
was considered unknown. Finally, the age, the injury codes, 
and the survival status have to be available. Table 2 shows the 
selection of cases from both registries. All data were selected 
from a 2-year period (January 2015–December 2016).
A subgroup analysis based on patients treated in the 
intensive care unit (ICU) was carried out, as this was where 
a relevant diference between both data sets existed. This 
subgroup excluded TARN cases where no intensive care stay 
was observed, and patients from both registries who died 
before ICU admission.
Table 2  Patient selection lowchart
a Multiple reasons for exclusions may apply
b After excluding isolated hip, burns, hanging and drowning
TR-DGU TARN
Patients documented in 2015–2016 81,479b 111,265b
Exclusionsa
 Non-German/non-UK − 10,917 − 8344
 ISS < 9 − 23,660 − 25,101
 Transfer in cases − 6289 − 11,948
 Early transfer out cases − 5353 − 1250
 Missing age, ISS, or outcome 45 0
Study population 40,638 64,622
Patients with intensive care treatment 35,803 11,744
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Statistics
In both registries, the predicted mortality rate from RISCII and 
PS14 were calculated according to the published rules (see 
“Appendix 1” and “Appendix 2”). As some of the predictors 
were diferent, a mapping exercise was carried out. For exam-
ple, pre-existing diseases were coded as pre-trauma ASA level 
in TR-DGU which was recommended in the Utstein European 
Core Dataset [9]. TARN used the Charlson Comorbiditiy Index 
(CCI) for grading the severity of pre-existing diseases [10]. This 
adjustment was based on the prevalence and mortality rates of 
patients with speciic CCI or ASA levels. For example, CCI 0 
was considered equivalent to ASA 1; CCI 1–5 to ASA 2; etc.
In both registries, the 30-day mortality was chosen as the 
primary outcome measure. Patients who were discharged 
alive earlier than 30 days after admission were considered 
as survivors. Patients who died in hospital beyond day 30 
were considered as survivors in this analysis. However, both 
hospital and 30-day mortality were reported.
The predicted mortality rate was calculated as the mean 
value across all patients and was presented as a percentage. 
The precision of each predictive score (in each database) is 
assessed from the comparison with the actually observed mor-
tality rate. The discrimination of a score describes the ability to 
give diferent predictions for survivors and non-survivors. The 
area under the receiver operation characteristics (ROC) curve 
is considered a summary measure for discrimination. For this 
value a 95% conidence interval was determined. But outcome 
prediction should not only be precise on average, i.e., in the 
whole group of patients, but also in subgroups with high and 
low risk of death. Calibration is usually measured with Hos-
mer–Lemeshow (H–L) goodnessᒧofᒧit statistics. It summarizes 
deviations from observed versus expected mortality rates in ten 
subgroups of increasing risk of death. A score should thus not 
only have a good performance on average, but also for high- and 
low-risk patients. The lower the H–L statistic, the better the 
calibration. Due to the huge number of cases in both registries. 
The respective p value should not be over-interpreted.
Analysis was performed using SPSS statistical software (ver-
sion 24, IBM Inc., Armonk, NY, USA, for TR-DGU data) and 
Stata 14 (StataCorp. 2015. Stata Statistical Software: Release 
14. College Station, TX: StataCorp LP for TARN data).
Results
During the 2 years observation period, 64,622 trauma patients 
from TARN and 40,638 patients from TR-DGU were available 
for this analysis. An overview about the basic characteristics 
of both data sets is given in Table 3. Patients in the TR-DGU 
were on average 10–15 years younger and 16% more likely to 
be male than in TARN (Table 1). Road traic collision was the 
most frequent mechanism in TR-DGU, while most patients in 
TARN were low falls. The rates of head injuries were compara-
ble, but TR-DGU patients sufered much more frequently from 
thoracic trauma (45% versus 27%). Patients from TR-DGU 
had a higher injury severity (19 versus 15 points) and 30-day 
mortality rate was 2.3 percentage points higher in TR-DGU. 
Late deaths beyond day 30 in hospital were a rare event in both 
registries (0.5% in TR-DGU and 1.0% in TARN). Eighty-eight 
percent of TR-DGU patients were treated on ICU. While only 
18% of TARN patients required intensive care.
Results from TR‑DGU
The RISC II score could be calculated in all patients, since 
only injury pattern and age were required as mandatory vari-
ables. However, on average 11.8 of 13 variables per patient 
used in the RISC II were available in TR-DGU. No imputa-
tion was performed; each score component has a category for 
missing information (see “Appendix 1”). Predicted mortality 
(11.2%) matched well with the observed mortality (11.7%), 
while PS14 predicted 16.4% deaths (Table 4). A few cases 
were excluded from PS14 calculation due to missing Glas-
gow Coma Scale data (no imputation of missing values per-
formed). The area under the ROC curve was higher for RISC 
II (0.933) than for PS14 (0.918, Fig. 1), and also H–L statistic 
was much lower for RISC II in the German data (Fig. 2a).
Results from TARN
In the TARN data the availability of prognoses was similar 
to TR-DGU for both scores. Outcome prediction with PS14 
(10.6%) was close to the observed mortality rate of 9.7%. The 
RISC II score predicted nearly twice as many deaths (17.7%) 
than observed (9.7%). The areas under the ROC curves 
was higher for PS14 (0.885) when compared with RISC II 
(0.861). The H–L statistic for RISC II was much higher than 
that of PS14 (3382 vs. 129, Table 4 and Fig. 2b). Due to the 
large sample size, all H–L statistics were signiicant.
Subgroup with intensive care
Subgroup analysis in patients who needed intensive care 
left 35,803 patients from TR-DGU and 11,744 patients from 
TARN. The demographic and injury characteristics of these 
groups were similar. Mean age difered by only 1 year, and 
ISS by 0.8 points (Table 3). The diference in prevalence of 
head trauma was only 3%, in thoracic trauma 5%, and 4% 
in abdominal trauma. The observed 30 days mortality rate 
was 10.8% in TR-DGU and 17.2% in TARN. The expected 
mortality based on PS14 was very similar in both registries: 
17.2% in TR-DGU patients, and 16.2% in TARN patients 
(Table 4). The RISC II score predicted a mortality of 11.2% 
and 17.2%, respectively. This was within 1% deviation range 
from the observed mortality in both registries.
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Table 3  Basic characteristics of included trauma patients
a Continuous measures were presented as mean/median (standard deviation)
b TR-DGU: pre-injury ASA 3–4; TARN: Charlson Comorbidity Index 6 +
c TR-DGU: < 3 m; TARN: < 2 m
d Patients discharged after day 30 were considered as survivors
Registry All patients ICU patients only
TR-DGU TARN TR-DGU TARN
Number of cases 40,638 64,622 35,803 11,744
Age (years)a 52.6/54 (22.3) 62.1/68.6 (25.3) 52.5/54 (22.3) 51.4/50.7 (23.4)
Male patients 69.6% 53.2% 70.2% 71.4%
Pre-existing  diseasesb 18.4% 14.7% 18.8% 10.4%
Penetrating trauma 4.0% 2.7% 3.9% 7.3%
Road traic accident 53.3% 21.1% 53.5% 39.3%
Low  fallc 24.1% 57.9% 24.0% 28.2%
Transportation by helicopter 21.4% 6.4% 22.8% 20.0%
Injury Severity Score (ISS)a 19.9/17 (11.3) 15.7/13 (8.8) 20.2/17 (10.9) 21.0/22.6 (11.9)
Relevant head injury (AIS ≥ 3) 37.7% 34.3% 40.1% 43.1%
Relevant thoracic injury (AIS ≥ 3) 44.9% 27.2% 45.5% 50.7%
Relevant abdominal injury (AIS ≥ 3) 10.5% 4.4% 10.8% 14.4%
Relevant extremity injury (AIS ≥ 3) 28.1% 32.3% 27.0% 19.5%
Isolated head injury (AIS head ≥ 3, else ≤ 1) 14.3% 25.3% 15.1% 21.7%
Treated on ICU 88.1% 18.2% 100% 100%
Length of stay in hospital (days)a 16.5/12 (16.5) 16.5/10 (21.8) 17.5/13 (17.0) 13/22.9 (31.3)
Died within 24 h 5.8% 2.2% 4.3% 3.2%
30 days  mortalityd 11.7% 9.7% 10.8% 17.2%
Hospital mortality 12.2% 10.7% 11.4% 18.5%
Table 4  Observed (30 days) and predicted mortality based on RISC II and PS14 in all patients and the subgroup with intensive care
Registry All patients ICU patients only
TR-DGU TARN TR-DGU TARN
RISC II
 Number of cases with prognosis 40,638 (100%) 64,622 (100%) 35,803 (100%) 11,744 (100%)
 Observed mortality (30 days) 11.7% 9.7% 10.8% 17.5%
 Expected mortality 11.2% 17.7% 11.2% 17.2%
 Expected mortality in survivors 6.2% 14.5% 6.2% 12.2%
 Expected mortality in non-survivors 52.1% 47.0% 52.1% 43.4%
 Area under the ROC curve 0.933 0.861 0.933 0.867
 95% conidence interval 0.929–0.937 0.857–0.866 0.929–0.937 0.858–0.875
 H–L goodness-of-it statistic 92.1; p < 0.001 4405.1; p < 0.001 81.7; p < 0.001 25.5; p = 0.005
PS14
 Number of cases with prognosis 39,489 (97.2%) 61,950 (95.9%) 34,881 (97.4%) 11,529 (98.2%)
 Observed mortality (30 days) 12.4% 9.7% 11.5% 17.2%
 Expected mortality 16.9% 10.6% 17.2% 16.2%
 Expected mortality in survivors 11.1% 7.6% 11.9% 9.3%
 Expected mortality in non-survivors 58.3% 38.5% 57.4% 42.8%
 Area under the ROC curve 0.918 0.885 0.908 0.863
 95% conidence interval 0.914–0.921 0.881–0.889 0.904–0.912 0.855–0.872
 H–L goodness-of-it statistic 1215.7; p < 0.001 126.8; p < 0.001 1640.4; p < 0.001 95.7; p < 0.001
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Discussion
Trauma scoring systems combine indings known to be asso-
ciated with a good or bad outcome into a single value which 
could be transformed into a risk of death estimator. Such ind-
ings could be based on the patient (age, pre-existing diseases), 
the injury mechanism (blunt/penetrating), type and severity of 
injuries (ISS, head injury), and the actual physiology (shock, 
unconsciousness, coagulopathy). They are usually developed 
using multivariate models to ind the appropriate weights 
for each of their components. Obviously, such models will 
provide an optimal adaptation to the development data set. 
Therefore, independent validation studies are necessary.
Both scores considered in this study have been developed 
and validated within their own registries. Such a validation has 
also been repeated here: the RISC II score has been applied 
to TR-DGU patients from 2015 to 16, and the PS14 has been 
applied to new TARN patients as well. As expected, the per-
formance of both scores is quite good: predicted and observed 
mortality lie within a range of 1%. This could mostly be 
explained by the fact that the system (deinition of variables; 
inclusion of patients; mode of data collection) has not changed. 
But what happens if a score is applied in a diferent setting?
The RISC II has been applied to British TARN patients, and 
the PS14 has been applied to German TR-DGU patients. In both 
settings, the performance was poor. The prediction of PS14 
(16.9% mortality) was higher than observed (12.4%) in Ger-
man patients, and the performance of RISC II was even worse in 
English patients (predicted 17.7% versus observed 9.7%).
One reason for this mismatch may be the large diferences in 
the patient groups, despite the uniform requirement of ISS ≥ 9. 
A striking diference was the need for intensive care, which is a 
pragmatic inclusion criterion for TR-DGU. Although the criteria 
for intensive care vary from country to country, only 18% of the 
TARN patients received intensive care. This small subgroup was 
quite comparable to the German patients in terms of age, ISS, and 
injury pattern. In that subgroup, the RISC II showed much better 
results (observed and predicted mortality difered by 0.3 percent-
age points only). This may also explain the bad performance in 
all TARN patients. Many of the TARN patients not admitted to 
ICU had missing laboratory values (completeness of base excess, 
INR, hemoglobin was < 5%). The RISC II assumes some average 
values there, but these average values were based on severe cases 
from the development data set. ICU admission is an inclusion 
criterion for TR-DGU. Thus many TARN patients with missing 
laboratory values (not treated on ICU) received a worse prognosis. 
If these laboratory values would have been available (and in a nor-
mal range), then risk of death based on RISC II would decrease. 
Thus, the application of RISC II in less severe cases with several 
missing data is not recommended and may lead to false high risk 
of death estimates. For application in non-ICU patients, the RISC 
II score seems inappropriate, or needs adaptation.
Fig. 1  ROC curves for RISC II and PS14 using all patients from the 
TR-DGU data set (n = 40,638). The areas under the curves were 0.933 
and 0.918, respectively
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Fig. 2  a Observed and predicted mortality in ten subgroups of 
equal size (risk bands according to PS14, n = 39,295) in TR-DGU. b 
Observed and predicted mortality in ten subgroups of equal size (risk 
bands according to RISCII, n = 64,622) in TARN
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While RISC II performed well in British ICU patients, 
PS14 did not in German patients. The main reason for PS14 
to not perform well in the TR-DGU is the inclusion criteria. 
The PS model was developed on a general trauma population 
which included patients with low severity, patients who were 
transferred from other hospitals after being stabilized and 
would have a higher chance of survival. The mortality rate 
in the TARN general population is around 6%; that is why 
it probably overestimates mortality in the TR-DGU setting.
There were also some diferences in data collection. Pre-
existing diseases, for example, are recorded with the CCI in 
TARN, while TR-DGU uses the pre-trauma ASA. Labora-
tory values are also rarely documented in TARN; such values 
may improve the prediction but cause a problem when miss-
ing. Furthermore, injury coding in TARN is done by experi-
enced coders, while TR-DGU applies an online coding tool 
with a simpliied AIS system. The PS14 score requires ive 
variables only (ISS, GCS, CCI, age and gender), while the 
RISC II combines 13 variables. The PS14 has been developed 
using all TARN patients, including transfers, and not just the 
selected cases here (primary admission with ISS ≥ 9, or inten-
sive care). Thus performance of PS14 is expected to be better 
in a large data set that also includes moderate trauma. The 
RISC II, on the other hand, considered patients with ISS ≥ 4 
in its development set, but only those with need of intensive 
care. All these diferences might afect the prognoses.
Finally, there might also be diferences in outcome in the two 
countries. Both are developed countries, but the health system is 
diferent. This refers to the pre-hospital care (doctor versus para-
medic at scene); emergency departments; the role of orthopedic 
or trauma surgery; intensive care; and the inancing system.
Although risk prediction scores should aim to improve 
their precision, and cross-validation studies like the pre-
sent one will contribute to this, the most important use 
of these tools would be an ongoing comparison over 
time, within one organization or hospital, with the aim to 
improve the observed/expected ratio and thus the outcome 
of severely injured patients
External validations of prediction models between regis-
tries like this one are needed, but may show that prediction 
models are not fully transferable to other health-care settings.
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Appendix 1: RISC II prognostic model 
of TR‑DGU
Variable Description
Worst and second worst injury AIS injury severity level; if only 
one injury was coded, the second 
worst injury was set to zero
Head injury AIS injury severity level of the 
body region ‘head’ as deined 
for ISS
Age Age in years at the time of acci-
dent, 10 categories
Sex Male/female
ASA Pre-trauma ASA (American 
Society of Anaesthesiologists) 
score, as deined in the Utstein 
European core data set [9]
Pupil reactivity and size Three categories according to the 
Eppendorf Cologne Scale [11]. 
The irst pre-hospital assessment 
was used; if missing, assessment 
on admission was used
Motor function Motor function from Glasgow 
Coma Scale, but reduced to 4 
categories: normal; directed; 
non-directed; and none. The irst 
pre-hospital assessment, if miss-
ing assessment on admission in 
non-intubated cases
Mechanism Blunt/penetrating
Blood pressure Systolic blood pressure (mmHg), 
irst measurement after admis-
sion; in case of missing values, 
the irst pre-hospital measure-
ment
Coagulation: INR International Normalized Ratio 
(INR); irst measurement after 
admission
Base deicit Base deicit, or base excess 
(mEq/l); irst measurement after 
admission
Hemoglobin Hemoglobin (g/dl); irst measure-
ment after admission
CPR Pre-hospital cardio-pulmonary 
resuscitation (CPR) in case of 
cardiac arrest
The ‘???’ below indicates the category used for missing val-
ues (coeicient is always 0).
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Appendix 2: PS14 predictive model of TARN
Predictors Coeicients p value 95% CI for 
odds ratios
√
10
ISS
− 0.8686
− 2.79052 < 0.001 0.0464 0.0812
log
e
(
ISS
10
)
− 0.2817 − 2.57574 < 0.001 0.0659 0.0879
GCS = 3 − 3.79637 < 0.001 0.0203 0.0248
GCS 4–5 − 2.73865 < 0.001 0.0557 0.0751
GCS 6–8 − 1.87664 < 0.001 0.1361 0.1722
GCS 9–12 − 1.29443 < 0.001 0.2477 0.3033
GCS 13–14 − 0.46062 < 0.001 0.5853 0.6801
GCS 15 (reference) 0.00000
GCS “Intubated” − 2.62397 < 0.001 0.0595 0.0884
CCI notknown − 0.44900 < 0.001 0.5919 0.6882
CCI 0 (reference) 0.00000
CCI 1–5 − 0.49572 < 0.001 0.5692 0.6519
CCI 6–10 − 0.96308 < 0.001 0.3474 0.4195
CCI > 10 − 1.59703 < 0.001 0.1791 0.2289
Age 0–5 − 0.00483 0.9770 0.7206 1.3745
Age 6–10 0.25323 0.2750 0.8174 2.0300
Age 11–15 − 0.08435 0.5780 0.6825 1.2378
Predictors Coeicients p value 95% CI for 
odds ratios
Age 16–44 (reference) 0.00000
Age 45–54 − 0.41388 < 0.001 0.5795 0.7542
Age 55–64 − 0.93229 < 0.001 0.3457 0.4482
Age 65–74 − 1.58082 < 0.001 0.1814 0.2335
Age ≥ 75 − 2.67520 < 0.001 0.0621 0.0765
Gender MALE (reference) 0.00000
Gender female − 0.17252 0.0290 0.7211 0.9821
Age 0–5 × female − 0.13805 0.5820 0.5322 1.4255
Age 6–10 × female 0.43973 0.3200 0.6518 3.6970
Age 11–15 × female 0.21675 0.4630 0.6961 2.2160
Age 45–54 × female − 0.06972 0.6000 0.7183 1.2110
Age 55–64 × female 0.17164 0.1590 0.9350 1.5075
Age 65–74 × female 0.25829 0.0220 1.0376 1.6155
Age ≥ 75 + × female 0.34770 < 0.001 1.1928 1.6806
Constant 5.28621 < 0.001
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